Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amidation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111116581A details a green one-pot synthesis for 2,9-diamide-1,10-phenanthroline compounds, offering significant cost reduction and improved purity for radiochemical applications.
Advanced preparation method for Iopromide eliminating bis-amide impurities. Streamlined process offers cost reduction in pharmaceutical manufacturing and scalable production.
Novel patent CN112250594B reveals high-yield synthesis for Vildagliptin intermediate. Reduces waste acid and costs for reliable pharmaceutical intermediates supplier scalability.
Patent CN114230555A reveals a cleaner chlorantraniliprole synthesis using boric acid catalysts, eliminating toxic reagents and simplifying solvent recovery for cost-effective manufacturing.
Patent CN121202870A discloses a high-yield synthesis route for 5-isopropyl-non-nefarnesone impurity standards, offering significant supply chain stability and cost optimization for pharmaceutical manufacturers.
Patent CN108430981A reveals a chromium-free synthesis route for herbicide intermediates. Achieve high purity and cost reduction in agrochemical intermediate manufacturing with scalable processes.
Patent CN107879955B details a high-purity glyburide synthesis using crown ether catalysis, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Patent CN104447539B enables efficient aromatic amide production. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Advanced preparation method for Iopromide using novel intermediates to eliminate bismer byproducts. Ensures high yield and purity for contrast agent manufacturing.
Advanced preparation method for Ioxilan contrast agent via CN100344606C. Offers reduced thionyl chloride usage, higher purity, and streamlined industrial scalability for global supply chains.
Patent CN108658826B reveals a novel boron-catalyzed route for vildagliptin, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN104058983A reveals a novel Ph3P/CBr4 catalytic system for high-purity amide compounds, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN108467360A reveals a mild amidation route for Apatinib intermediates, offering cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN111592531A details a streamlined amidation-reduction process for Afuresertib, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel MOF-catalyzed route eliminates genotoxic 2-MBT impurities effectively. High-purity ceftiofur sodium manufacturing for veterinary pharmaceutical supply chains ensures safety and compliance.
Patent CN102264715B reveals a scalable cinchonidine salt resolution process for HCV inhibitors, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN111943930A reveals a mild copper-catalyzed route for Lasmiditan. This process eliminates noble metals, offering significant cost reduction and scalable manufacturing for API intermediates.
Patent CN115304506A reveals a green boron-catalyzed transamidation method. Achieve high-purity secondary amides with reduced costs and simplified supply chains for pharmaceutical manufacturing.
Patent CN1350525A reveals a high-yield 4-step process for 1,3,4-oxadiazole derivatives, offering significant cost reduction in pharmaceutical intermediate manufacturing compared to conventional methods.
Patent CN113801903B reveals enzymatic route for sitagliptin intermediate offering high purity and supply chain stability for global API manufacturers.